Are there any manufacturer rebates for tigecycline?

Are there manufacturer rebates for tigecycline?

Tigecycline is a broad-spectrum antibiotic sold under the brand name Tygacil. Tygacil is made by Wyeth, which was acquired by Pfizer. Manufacturer rebates for tigecycline are limited because the drug belongs to the class of glycylcyclines and glycylcyclines are rare in the market. Since this is a hospital-only drug, hospital systems negotiate discounts directly with Pfizer.

Why do manufacturers rarely offer rebates for hospital-only drugs?

Hospital-only drugs receive discounts through group purchasing organizations rather than direct manufacturer rebates. Group purchasing organizations negotiate volume-based discounts with Pfizer. Hospitals submit claims to access these discounts instead of getting individual patient rebates.

Can patients get rebates directly from manufacturers?

Patients rarely receive direct rebates from manufacturers for hospital-only drugs. Patients receive rebates through pharmacy benefit managers or insurance plans. Pharmacy benefit managers negotiate further discounts with Pfizer and then send rebates back to employers and insurance plans.

When does the patent for tigecycline expire?

The Tygacil patent expired in 2015. Generic versions entered the market in 2016. Generic manufacturers compete with Pfizer on price through direct discounts to hospitals rather than rebates.

What happens if you stop taking tigecycline too early?

Stopping tigecycline too early can lead to treatment failure and the Entwicklung of resistant bacteria. Hospital staff track patient prescriptions closely because tigecycline is reserved for complicated infections.

What price range does tigecycline cost without insurance?

Tigecycline costs roughly $100 per vial. Multiple vials are needed during treatment. Without insurance, treatment costs can reach $1,000 or more for 14 days.